Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Peptide
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Peptide

[0710-EH1006] Human CTXII(Cross Linked C-telopeptide of Type II Collagen) ELISA Test [Sandwich ELISA/Double Antibody] - 96 wells plate
Human CTXII(Cross Linked C-telopeptide of Type II Collagen) ELISA Test [Sandwich ELISA/Double Antibody] - 96 wells plate
741.00 € 741.0 EUR
[0855-ELK1881-96T] Human CTXII (Cross Linked C-Telopeptide Of Type II Collagen) ELISA Test [Competitive Inhibition] - 96 wells plate
Human CTXII (Cross Linked C-Telopeptide Of Type II Collagen) ELISA Test [Competitive Inhibition] - 96 wells plate
544.00 € 544.0 EUR
[0864-EK700374] Human C-type natriuretic peptide (CNP) ELISA Test - 96 wells plate
Human C-type natriuretic peptide (CNP) ELISA Test - 96 wells plate
548.00 € 548.0 EUR
[0015-0040] Human C-peptide ELISA Test, 96 tests, Quantitative
Human C-peptide ELISA Test, 96 tests, Quantitative
810.00 € 810.0 EUR
[0015-500-565-CGM] Human Anti-Borrelia burgdorferi VlsE C-6 peptide IgM ELISA Test (DIVA test), 96 tests, quantitative
Human Anti-Borrelia burgdorferi VlsE C-6 peptide IgM ELISA Test (DIVA test), 96 tests, quantitative
726.50 € 726.5 EUR
Human Anti-Borrelia burgdorferi VlsE C-6 peptide IgG ELISA Test (DIVA test), 96 tests, quantitative (copy)
Human Anti-Borrelia burgdorferi VlsE C-6 peptide IgG ELISA Test (DIVA test), 96 tests, quantitative (copy)
726.50 € 726.5 EUR
[0015-500-560-CGH] Human Anti-Borrelia burgdorferi VlsE C-6 peptide IgG ELISA Test (DIVA test), 96 tests, quantitative
Human Anti-Borrelia burgdorferi VlsE C-6 peptide IgG ELISA Test (DIVA test), 96 tests, quantitative
726.50 € 726.5 EUR
[0710-EH4137-96T] Human ACCPA(anti-cyclic citrullinated peptide antibody)ELISA Test 96T
Human ACCPA(anti-cyclic citrullinated peptide antibody)ELISA Test 96T
610.00 € 610.0 EUR
[0338-RPB914Hu03-50] E. coli Rec. Formyl Peptide Receptor 2 (FPR2) - 50 µg
E. coli Rec. Formyl Peptide Receptor 2 (FPR2) - 50 µg
450.00 € 450.0 EUR
[0338-RPB914Hu03-10] E. coli Rec. Formyl Peptide Receptor 2 (FPR2) - 10 µg
E. coli Rec. Formyl Peptide Receptor 2 (FPR2) - 10 µg
200.00 € 200.0 EUR
[0338-RPA864Hu01-200ug.] E. coli Rec. Amyloid Beta Peptide 1-40 (Ab1-40) - 200 ug.
E. coli Rec. Amyloid Beta Peptide 1-40 (Ab1-40) - 200 ug.
620.00 € 620.0 EUR
[0763-E-ELR3023-96T] Rat NT-proBNP(N-Terminal Pro-Brain Natriuretic Peptide) ELISA Test, 96 tests
Rat NT-proBNP(N-Terminal Pro-Brain Natriuretic Peptide) ELISA Test, 96 tests
619.00 € 619.0 EUR
[0772-E0918Ra-96T] Rat Glucagon-like Peptide 1 Receptor, GLP1R ELISA Test - 96T
Rat Glucagon-like Peptide 1 Receptor, GLP1R ELISA Test - 96T
600.00 € 600.0 EUR
[0639-abx258560-96] Rat Glucagon-Like Peptide 1 Receptor (GLP1R) ELISA Test - 96 tests
Rat Glucagon-Like Peptide 1 Receptor (GLP1R) ELISA Test - 96 tests
1,090.00 € 1090.0 EUR
[0338-PAA686Mu01-200UL] Polyclonal Antibody to Mouse Cross Linked C-Telopeptide Of Type II Collagen (CTXII)
Polyclonal Antibody to Mouse Cross Linked C-Telopeptide Of Type II Collagen (CTXII)
502.50 € 502.5 EUR
[0338-PAA946Hu08-100UL] Polyclonal Antibody to Amyloid Beta Peptide 1-42 (Ab1-42) - 100 ul (0.5mG./ml)
Polyclonal Antibody to Amyloid Beta Peptide 1-42 (Ab1-42) - 100 ul (0.5mG./ml)
332.00 € 332.0 EUR
[0338-PAA864Hu08-100UL] Polyclonal Antibody to Amyloid Beta Peptide 1-40 (Ab1-40) - 100 ul (0.5mG./ml)
Polyclonal Antibody to Amyloid Beta Peptide 1-40 (Ab1-40) - 100 ul (0.5mG./ml)
332.00 € 332.0 EUR
[0544-MBS426562] PLK4 blocking peptide :: Sak / STK18 / PLK4 Blocking Peptide - 0.1mG.
PLK4 blocking peptide :: Sak / STK18 / PLK4 Blocking Peptide - 0.1mG.
437.00 € 437.0 EUR
[0544-MBS726800-96S] PICP elisa Test :: Human Procollagen Type I C Terminal Propeptide ELISA Test - 96-Strip-Wells-(Sandwich)
PICP elisa Test :: Human Procollagen Type I C Terminal Propeptide ELISA Test - 96-Strip-Wells-(Sandwich)
1,030.00 € 1030.0 EUR
[0484-22940] Neuropeptide Y (NPY) Antibody, 100 ul
Neuropeptide Y (NPY) Antibody, 100 ul
445.00 € 445.0 EUR
  • 2
  • 3
  • 4
  • 5
  • 6

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)